Abstract
Mitochondrial DNA (mtDNA) replicates continuously. The minimal mitochondrial replisome consists of the DNA polymerase gamma (pol g), the mtDNA helicase Twinkle, and the mitochondrial single-stranded binding protein, all encoded by nuclear genes. Pol g is responsible for mtDNA replication and repair and is composed by a catalytic subunit (POLG) and two identical accessory subunits, POLG2. Mutations in POLG, POLG2, and Twinkle result in multiple mtDNA deletions and/or mtDNA depletion, causing disease. Multiple mtDNA deletions accumulate along the years and usually give rise to late-onset disease. Autosomal-dominant mutations in POLG and POLG2 lead to progressive external ophthalmoplegia (PEO) that can occur as sole clinical manifestation of the disease or in association with other clinical features, such as myopathy, exercise intolerance, or predominantly axonal peripheral neuropathy. Autosomal-recessive POLG mutations lead to a broader spectrum of clinical phenotypes ranging from Alpers syndrome to ataxia-neuropathy syndrome with or without epilepsy to PEO. Heterozygous mutations in Twinkle cause PEO, while recessive mutations in this protein result in early-onset ataxia and epileptic encephalopathy, associated with mtDNA depletion. In addition to the genes encoding proteins involved in mtDNA replication, mutations in nucleotide translocator 1 (ANT1) also result in multiple mtDNA deletions responsible for PEO.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Masuyama M, Iida R, Takatsuka H, Yasuda T, Matsuki T (2005) Quantitative change in mitochondrial DNA content in various mouse tissues during aging. Biochimica Et Biophysica Acta 1723(1–3):302–308
Shoubridge EA, Wai T (2007) Mitochondrial DNA and the mammalian oocyte. Curr Top Dev Biol 77:87–111
Korhonen JA, Pham XH, Pellegrini M, Falkenberg M (2004) Reconstitution of a minimal mtDNA replisome in vitro. EMBO J 23(12):2423–2429
Kaukonen J, Juselius JK, Tiranti V et al (2000) Role of adenine nucleotide translocator 1 in mtDNA maintenance. Science 289(5480):782–785
Lee YS, Kennedy WD, Yin YW (2009) Structural insight into processive human mitochondrial DNA synthesis and disease-related polymerase mutations. Cell 139(2):312–324
Lee YS, Lee S, Demeler B, Molineux IJ, Johnson KA, Yin YW (2010) Each monomer of the dimeric accessory protein for human mitochondrial DNA polymerase has a distinct role in conferring processivity. J Biol Chem 285(2):1490–1499
Johnson AA, Johnson KA (2001) Exonuclease proofreading by human mitochondrial DNA polymerase. J Biol Chem 276(41):38097–38107
Johnson AA, Tsai Y, Graves SW, Johnson KA (2000) Human mitochondrial DNA polymerase holoenzyme: reconstitution and characterization. Biochemistry 39(7):1702–1708
Di Re M, Sembongi H, He J et al (2009) The accessory subunit of mitochondrial DNA polymerase gamma determines the DNA content of mitochondrial nucleoids in human cultured cells. Nucleic Acids Res 37(17):5701–5713
Hudson G, Chinnery PF (2006) Mitochondrial DNA polymerase-gamma and human disease. Hum Mol Genet 15(Spec No 2):R244–R252
Van Goethem G, Luoma P, Rantamaki M et al (2004) POLG mutations in neurodegenerative disorders with ataxia but no muscle involvement. Neurology 63(7):1251–1257
Milone M, Brunetti-Pierri N, Tang LY et al (2008) Sensory ataxic neuropathy with ophthalmoparesis caused by POLG mutations. Neuromuscul Disord 18(8):626–632
Tang S, Wang J, Lee NC et al (2011) Mitochondrial DNA polymerase gamma mutations: an ever expanding molecular and clinical spectrum. J Med Genet 48(10):669–681
Wong LJ, Naviaux RK, Brunetti-Pierri N et al (2008) Molecular and clinical genetics of mitochondrial diseases due to POLG mutations. Hum Mutat 29(9):E150–E172
Fadic R, Russell JA, Vedanarayanan VV, Lehar M, Kuncl RW, Johns DR (1997) Sensory ataxic neuropathy as the presenting feature of a novel mitochondrial disease. Neurology 49(1):239–245
Van Goethem G, Martin JJ, Dermaut B et al (2003) Recessive POLG mutations presenting with sensory and ataxic neuropathy in compound heterozygote patients with progressive external ophthalmoplegia. Neuromuscul Disord 13(2):133–142
Hakonen AH, Heiskanen S, Juvonen V et al (2005) Mitochondrial DNA polymerase W748S mutation: a common cause of autosomal recessive ataxia with ancient European origin. Am J Hum Genet 77(3):430–441
Lax NZ, Whittaker RG, Hepplewhite PD et al (2012) Sensory neuronopathy in patients harbouring recessive polymerase gamma mutations. Brain: J Neurol 135(Pt 1):62–71
Schicks J, Synofzik M, Schulte C, Schols L (2010) POLG, but not PEO1, is a frequent cause of cerebellar ataxia in Central Europe. Movement Disord: Official J Movement Disord Soc 25(15):2678–2682
Lax NZ, Hepplewhite PD, Reeve AK et al (2012) Cerebellar ataxia in patients with mitochondrial DNA disease: a molecular clinicopathological study. J Neuropathol Exp Neurol 71(2):148–161
Harrower T, Stewart JD, Hudson G et al (2008) POLG1 mutations manifesting as autosomal recessive axonal Charcot-Marie-Tooth disease. Arch Neurology 65(1):133–136
Mehta AR, Fox SH, Tarnopolsky M, Yoon G (2011) Mitochondrial mimicry of multiple system atrophy of the cerebellar subtype. Movement Disord: Official J Movement Disorder Soc 26(4):753–755
Milone M, Wang J, Liewluck T, Chen LC, Leavitt JA, Wong LJ (2011) Novel POLG splice site mutation and optic atrophy. Arch Neurol 68(6):806–811
Horvath R, Hudson G, Ferrari G et al (2006) Phenotypic spectrum associated with mutations of the mitochondrial polymerase gamma gene. Brain 129(Pt 7):1674–1684
Hinnell C, Haider S, Delamont S, Clough C, Hadzic N, Samuel M (2012) Dystonia in mitochondrial spinocerebellar ataxia and epilepsy syndrome associated with novel recessive POLG mutations. Movement Disord: Official J Movement Disorder Soc 27(1):162–163
Deschauer M, Tennant S, Rokicka A et al (2007) MELAS associated with mutations in the POLG1 gene. Neurology 68(20):1741–1742
Tang S, Dimberg EL, Milone M, Wong LJ (2011) Mitochondrial neurogastrointestinal encephalomyopathy (MNGIE)-like phenotype: an expanded clinical spectrum of POLG1 mutations. J Neurol
Engelsen BA, Tzoulis C, Karlsen B et al (2008) POLG1 mutations cause a syndromic epilepsy with occipital lobe predilection. Brain 131(Pt 3):818–828
Tzoulis C, Engelsen BA, Telstad W et al (2006) The spectrum of clinical disease caused by the A467T and W748S POLG mutations: a study of 26 cases. Brain 129(Pt 7):1685–1692
Kollberg G, Moslemi AR, Darin N et al (2006) POLG1 mutations associated with progressive encephalopathy in childhood. J Neuropathol Exp Neurol 65(8):758–768
Uusimaa J, Hinttala R, Rantala H et al (2008) Homozygous W748S mutation in the POLG1 gene in patients with juvenile-onset Alpers syndrome and status epilepticus. Epilepsia 49(6):1038–1045
Saneto RP, Lee IC, Koenig MK et al (2010) POLG DNA testing as an emerging standard of care before instituting valproic acid therapy for pediatric seizure disorders. Seizure 19(3):140–146
Chinnery PF, Zeviani M (2008) 155th ENMC workshop: polymerase gamma and disorders of mitochondrial DNA synthesis, 21–23 September 2007, Naarden, The Netherlands. Neuromuscul Disord. 18(3):259–267
Visser NA, Braun KP, Leijten FS, van Nieuwenhuizen O, Wokke JH, van den Bergh WM (2011) Magnesium treatment for patients with refractory status epilepticus due to POLG1-mutations. J Neurol 258(2):218–222
Van Goethem G, Dermaut B, Lofgren A, Martin JJ, Van Broeckhoven C (2001) Mutation of POLG is associated with progressive external ophthalmoplegia characterized by mtDNA deletions. Nat Genet 28(3):211–212
Spelbrink JN, Li FY, Tiranti V et al (2001) Human mitochondrial DNA deletions associated with mutations in the gene encoding Twinkle, a phage T7 gene 4-like protein localized in mitochondria. Nat Genet 28(3):223–231
Longley MJ, Clark S, Yu Wai Man C et al (2006) Mutant POLG2 disrupts DNA polymerase gamma subunits and causes progressive external ophthalmoplegia. Am J Human Genet 78(6):1026–1034
Hudson G, Amati-Bonneau P, Blakely EL et al (2008) Mutation of OPA1 causes dominant optic atrophy with external ophthalmoplegia, ataxia, deafness and multiple mitochondrial DNA deletions: a novel disorder of mtDNA maintenance. Brain 131(Pt 2):329–337
Goffart S, Cooper HM, Tyynismaa H, Wanrooij S, Suomalainen A, Spelbrink JN (2009) Twinkle mutations associated with autosomal dominant progressive external ophthalmoplegia lead to impaired helicase function and in vivo mtDNA replication stalling. Hum Mol Genet 18(2):328–340
Tyynismaa H, Sun R, Ahola-Erkkila S et al (2012) Thymidine kinase 2 mutations in autosomal recessive progressive external ophthalmoplegia with multiple mitochondrial DNA deletions. Hum Mol Genet 21(1):66–75
Lamantea E, Tiranti V, Bordoni A et al (2002) Mutations of mitochondrial DNA polymerase gammaA are a frequent cause of autosomal dominant or recessive progressive external ophthalmoplegia. Annals Neurol 52(2):211–219
Luoma P, Melberg A, Rinne JO et al (2004) Parkinsonism, premature menopause, and mitochondrial DNA polymerase gamma mutations: clinical and molecular genetic study. Lancet 364(9437):875–882
Horvath R, Hudson G, Ferrari G et al (2006) Phenotypic spectrum associated with mutations of the mitochondrial polymerase gamma gene. Brain: J Neurol 129(Pt 7):1674–1684
Pagnamenta AT, Hargreaves IP, Duncan AJ et al (2006) Phenotypic variability of mitochondrial disease caused by a nuclear mutation in complex II. Mol Genet Metab 89(3):214–221
Echaniz-Laguna A, Chassagne M, de Seze J et al (2010) POLG1 variations presenting as multiple sclerosis. Arch Neurol 67(9):1140–1143
Van Goethem G, Schwartz M, Lofgren A, Dermaut B, Van Broeckhoven C, Vissing J (2003) Novel POLG mutations in progressive external ophthalmoplegia mimicking mitochondrial neurogastrointestinal encephalomyopathy. Eur J Hum Genet 11(7):547–549
Giordano C, Pichiorri F, Blakely EL et al (2010) Isolated distal myopathy of the upper limbs associated with mitochondrial DNA depletion and polymerase gamma mutations. Arch Neurol 67(9):1144–1146
Giordano C, Powell H, Leopizzi M et al (2009) Fatal congenital myopathy and gastrointestinal pseudo-obstruction due to POLG1 mutations. Neurol 72(12):1103–1105
Tzoulis C, Pa**ji M, Fiskestrand T, Roste LS, Bindoff LA (2009) Mitochondrial DNA depletion in progressive external ophthalmoplegia caused by POLG1 mutations. Acta Neurol Scand Suppl 2009(189):38–41
Isohanni P, Hakonen AH, Euro L et al (2011) POLG1 manifestations in childhood. Neurology 76(9):811–815
Winterthun S, Ferrari G, He L et al (2005) Autosomal recessive mitochondrial ataxic syndrome due to mitochondrial polymerase gamma mutations. Neurol 64(7):1204–1208
de Vries MC, Rodenburg RJ, Morava E et al (2007) Multiple oxidative phosphorylation deficiencies in severe childhood multi-system disorders due to polymerase gamma (POLG1) mutations. Eur J Pediat 166(3):229–234
Trifunovic A, Wredenberg A, Falkenberg M et al (2004) Premature ageing in mice expressing defective mitochondrial DNA polymerase. Nat 429(6990):417–423
Bailey LJ, Cluett TJ, Reyes A et al (2009) Mice expressing an error-prone DNA polymerase in mitochondria display elevated replication pausing and chromosomal breakage at fragile sites of mitochondrial DNA. Nucleic Acids Res 37(7):2327–2335
Ahlqvist KJ, Hamalainen RH, Yatsuga S et al (2012) Somatic progenitor cell vulnerability to mitochondrial DNA mutagenesis underlies progeroid phenotypes in Polg mutator mice. Cell Metab 15(1):100–109
Walter MC, Czermin B, Muller-Ziermann S et al (2010) Late-onset ptosis and myopathy in a patient with a heterozygous insertion in POLG2. J Neurol 257(9):1517–1523
Young MJ, Longley MJ, Li FY, Kasiviswanathan R, Wong LJ, Copeland WC (2011) Biochemical analysis of human POLG2 variants associated with mitochondrial disease. Hum Mol Genet 20(15):3052–3066
Chan SS, Longley MJ, Copeland WC (2005) The common A467T mutation in the human mitochondrial DNA polymerase (POLG) compromises catalytic efficiency and interaction with the accessory subunit. J Biol Chem 280(36):31341–31346
Michiels S, Danoy P, Dessen P et al (2007) Polymorphism discovery in 62 DNA repair genes and haplotype associations with risks for lung and head and neck cancers. Carcinogenesis 28(8):1731–1739
Nakano M, Tashiro K (2011) Association studies getting broader: a commentary on ‘A polymorphism of the POLG2 gene is genetically associated with the invasiveness of urinary bladder cancer in Japanese males’. J Hum Genet 56(8):550–551
Tyynismaa H, Sembongi H, Bokori-Brown M et al (2004) Twinkle helicase is essential for mtDNA maintenance and regulates mtDNA copy number. Hum Mol Genet 13(24):3219–3227
Farge G, Holmlund T, Khvorostova J, Rofougaran R, Hofer A, Falkenberg M (2008) The N-terminal domain of TWINKLE contributes to single-stranded DNA binding and DNA helicase activities. Nucleic Acids Res 36(2):393–403
Jemt E, Farge G, Backstrom S, Holmlund T, Gustafsson CM, Falkenberg M (2011) The mitochondrial DNA helicase TWINKLE can assemble on a closed circular template and support initiation of DNA synthesis. Nucleic Acids Res 39(21):9238–9249
Guo S, Tabor S, Richardson CC (1999) The linker region between the helicase and primase domains of the bacteriophage T7 gene 4 protein is critical for hexamer formation. J Biol Chem 274(42):30303–30309
Van Hove JL, Cunningham V, Rice C et al (2009) Finding twinkle in the eyes of a 71-year-old lady: a case report and review of the genotypic and phenotypic spectrum of TWINKLE-related dominant disease. Am J Med Genet Part A 149A(5):861–867
Patel SS, Picha KM (2000) Structure and function of hexameric helicases. Annu Rev Biochem 69:651–697
Korhonen JA, Pande V, Holmlund T et al (2008) Structure-function defects of the TWINKLE linker region in progressive external ophthalmoplegia. J Mol Biol 377(3):691–705
Shutt TE, Gray MW (2006) Twinkle, the mitochondrial replicative DNA helicase, is widespread in the eukaryotic radiation and may also be the mitochondrial DNA primase in most eukaryotes. J Mol Evol 62(5):588–599
Suomalainen A, Majander A, Wallin M et al (1997) Autosomal dominant progressive external ophthalmoplegia with multiple deletions of mtDNA: clinical, biochemical, and molecular genetic features of the 10q-linked disease. Neurology 48(5):1244–1253
Fratter C, Gorman GS, Stewart JD et al (2010) The clinical, histochemical, and molecular spectrum of PEO1 (Twinkle)-linked adPEO. Neurology 74(20):1619–1626
Virgilio R, Ronchi D, Hadjigeorgiou GM et al (2008) Novel Twinkle (PEO1) gene mutations in mendelian progressive external ophthalmoplegia. J Neurol 255(9):1384–1391
Kiechl S, Horvath R, Luoma P et al (2004) Two families with autosomal dominant progressive external ophthalmoplegia. J Neurol Neurosurg Psychiatry 75(8):1125–1128
Hudson G, Deschauer M, Busse K, Zierz S, Chinnery PF (2005) Sensory ataxic neuropathy due to a novel C10Orf2 mutation with probable germline mosaicism. Neurology 64(2):371–373
Baloh RH, Salavaggione E, Milbrandt J, Pestronk A (2007) Familial parkinsonism and ophthalmoplegia from a mutation in the mitochondrial DNA helicase twinkle. Arch Neurol 64(7):998–1000
Bohlega S, Van Goethem G, Al Semari A et al (2009) Novel Twinkle gene mutation in autosomal dominant progressive external ophthalmoplegia and multisystem failure. Neuromuscul Disord 19(12):845–848
Echaniz-Laguna A, Chanson JB, Wilhelm JM et al (2010) A novel variation in the Twinkle linker region causing late-onset dementia. Neurogenetics 11(1):21–25
Lewis S, Hutchison W, Thyagarajan D, Dahl HH (2002) Clinical and molecular features of adPEO due to mutations in the Twinkle gene. J Neurol Sci 201(1–2):39–44
Nikali K, Suomalainen A, Saharinen J et al (2005) Infantile onset spinocerebellar ataxia is caused by recessive mutations in mitochondrial proteins Twinkle and Twinky. Hum Mol Genet 14(20):2981–2990
Lonnqvist T, Paetau A, Valanne L, Pihko H (2009) Recessive twinkle mutations cause severe epileptic encephalopathy. Brain: J Neurol 132(Pt 6):1553–1562
Hakonen AH, Davidzon G, Salemi R et al (2007) Abundance of the POLG disease mutations in Europe, Australia, New Zealand, and the United States explained by single ancient European founders. Eur J Hum Genet 15(7):779–783
Sarzi E, Goffart S, Serre V et al (2007) Twinkle helicase (PEO1) gene mutation causes mitochondrial DNA depletion. Annals Neurol 62(6):579–587
Hakonen AH, Isohanni P, Paetau A, Herva R, Suomalainen A, Lonnqvist T (2007) Recessive Twinkle mutations in early onset encephalopathy with mtDNA depletion. Brain: J Neurol 130(Pt 11):3032–3040
Patel G, Johnson DS, Sun B et al (2011) A257T linker region mutant of T7 helicase-primase protein is defective in DNA loading and rescued by T7 DNA polymerase. J Biol Chem 286(23):20490–20499
Holmlund T, Farge G, Pande V, Korhonen J, Nilsson L, Falkenberg M (2009) Structure-function defects of the twinkle amino-terminal region in progressive external ophthalmoplegia. Biochimica Et Biophysica Acta 1792(2):132–139
Tyynismaa H, Mjosund KP, Wanrooij S et al (2005) Mutant mitochondrial helicase Twinkle causes multiple mtDNA deletions and a late-onset mitochondrial disease in mice. Proc Natl Acad Sci U S A 102(49):17687–17692
Pohjoismaki JL, Goffart S, Spelbrink JN (2011) Replication stalling by catalytically impaired Twinkle induces mitochondrial DNA rearrangements in cultured cells. Mitochondrion 11(4):630–634
Levy SE, Chen YS, Graham BH, Wallace DC (2000) Expression and sequence analysis of the mouse adenine nucleotide translocase 1 and 2 genes. Gene 254(1–2):57–66
Huang SG, Odoy S, Klingenberg M (2001) Chimers of two fused ADP/ATP carrier monomers indicate a single channel for ADP/ATP transport. Arch Biochem Biophys 394(1):67–75
Faustin B, Rossignol R, Rocher C, Benard G, Malgat M, Letellier T (2004) Mobilization of adenine nucleotide translocators as molecular bases of the biochemical threshold effect observed in mitochondrial diseases. J Biol Chem 279(19):20411–20421
Benjamin F, Rodrigue R, Aurelien D et al (2011) The respiratory-dependent assembly of ANT1 differentially regulates Bax and Ca2+ mediated cytochrome c release. Front Biosci (Elite Ed) 3:395–409
Pebay-Peyroula E, Dahout-Gonzalez C, Kahn R, Trezeguet V, Lauquin GJ, Brandolin G (2003) Structure of mitochondrial ADP/ATP carrier in complex with carboxyatractyloside. Nature 426(6962):39–44
Brandolin G, Boulay F, Dalbon P, Vignais PV (1989) Orientation of the N-terminal region of the membrane-bound ADP/ATP carrier protein explored by antipeptide antibodies and an arginine-specific endoprotease. Evidence that the accessibility of the N-terminal residues depends on the conformational state of the carrier. Biochemistry 28(3):1093–1100
Walker JE, Runswick MJ (1993) The mitochondrial transport protein superfamily. J Bioenerg Biomembr 25(5):435–446
Napoli L, Bordoni A, Zeviani M et al (2001) A novel missense adenine nucleotide translocator-1 gene mutation in a Greek adPEO family. Neurology 57(12):2295–2298
Komaki H, Fukazawa T, Houzen H, Yoshida K, Nonaka I, Goto Y (2002) A novel D104G mutation in the adenine nucleotide translocator 1 gene in autosomal dominant progressive external ophthalmoplegia patients with mitochondrial DNA with multiple deletions. Annals Neurol 51(5):645–648
Siciliano G, Tessa A, Petrini S et al (2003) Autosomal dominant external ophthalmoplegia and bipolar affective disorder associated with a mutation in the ANT1 gene. Neuromuscul Disord 13(2):162–165
Deschauer M, Hudson G, Muller T, Taylor RW, Chinnery PF, Zierz S (2005) A novel ANT1 gene mutation with probable germline mosaicism in autosomal dominant progressive external ophthalmoplegia. Neuromuscul Disord 15(4):311–315
Palmieri L, Alberio S, Pisano I et al (2005) Complete loss-of-function of the heart/muscle-specific adenine nucleotide translocator is associated with mitochondrial myopathy and cardiomyopathy. Hum Mol Genet 14(20):3079–3088
Graham BH, Waymire KG, Cottrell B, Trounce IA, MacGregor GR, Wallace DC (1997) A mouse model for mitochondrial myopathy and cardiomyopathy resulting from a deficiency in the heart/muscle isoform of the adenine nucleotide translocator. Nat Genet 16(3):226–234
Kawamata H, Manfredi G (2011) Introduction to neurodegenerative diseases and related techniques. Methods Mol Biol 793:3–8
Park KP, Kim HS, Kim ES, Park YE, Lee CH, Kim DS (2011) SLC25A4 and C10ORF2 mutations in autosomal dominant progressive external ophthalmoplegia. J Clin Neurol 7(1):25–30
Acknowledgments
Margherita Milone thanks Lee-Jun Wong for her constructive comments on the manuscript. Margherita Milone receives research support by the Mayo Clinic CTSA through NIH/NCRR grant number UL1 RR024150.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Milone, M. (2013). Mitochondrial DNA Multiple Deletion Syndromes, Autosomal Dominant and Recessive (POLG, POLG2, TWINKLE and ANT1). In: Wong, LJ. (eds) Mitochondrial Disorders Caused by Nuclear Genes. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-3722-2_8
Download citation
DOI: https://doi.org/10.1007/978-1-4614-3722-2_8
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4614-3721-5
Online ISBN: 978-1-4614-3722-2
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)